NCT02697851View on ClinicalTrials.gov

Pharmacokinetic Effect of Evotaz/Microgynon Co-administration

PHASE1TerminatedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions

HIV

Interventions

DRUG

Microgynon 30®

DRUG

Evotaz®

Trial Locations (1)

SW10 9NH

St Stephen's Centre, Chelsea and Westminster Hospital NHS Foundation Trust, London

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

St Stephens Aids Trust

OTHER